PCOS is the most common endocrine disorder amongst premenopausal women, with a prevalence of 5-10% (1) . Insulin resistance (IR) is present in 50-70% (2) of these women. Women with PCOS are more insulin resistant than age-and BMI-matched controls, have a higher incidence of diabetes (3) and have a more deleterious cardiovascular risk profile (4) than women without the condition. As IR makes an important contribution to CVD risk factors, the aim of the present study was to determine whether it is PCOS per se, or the IR component that is impacting most on CVD risk.
When compared with equally insulin-resistant age-and BMI-matched controls, women with PCOS have an equivalent CVD risk lipid profile; however, differences in WHR, leucocyte count and HMW adiponectin remain. Further work is required to ascertain the cause and impact of lower HMW in women with PCOS and to explore the possible link between IR, HMW adiponectin, low-grade inflammation and the liver in this condition.
